Literature DB >> 24699802

Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults.

Mohammad Talaei1, Woon-Puay Koh2, Rob M van Dam3, Jian-Min Yuan4, An Pan5.   

Abstract

Although soy food has been recommended because of its presumed cardiovascular benefits, the long-term prospective association between habitual soy food intake and cardiovascular disease mortality remains unclear. This study aimed to evaluate the relation of soy protein and isoflavone intake with the risk of cardiovascular disease mortality in middle-aged and older Chinese adults residing in Singapore. The Singapore Chinese Health Study is a population-based study that recruited 63,257 Chinese adults aged 45-74 y from 1993 to 1998. Usual diet was measured at recruitment by using a validated semiquantitative food-frequency questionnaire, and mortality information was identified via registry linkage until 31 December 2011. Cox proportional hazards models were used to calculate HRs, with adjustment for potential confounders. The median intake was 5.2 g/d for soy protein, 15.8 mg/d for soy isoflavones, and 87.4 g/d for soy expressed as tofu equivalents. We documented 4780 cardiovascular deaths during 890,473 person-years of follow-up. After adjustment for sociodemographic, lifestyle, and other dietary factors, soy protein intake was not significantly associated with cardiovascular disease mortality: HRs (95% CIs) were 1.00 (reference), 1.02 (0.94, 1.11), 1.02 (0.93, 1.11), and 1.06 (0.97, 1.17) for increasing quartiles of soy protein (P-trend = 0.24). Similarly, no significant association was observed for soy isoflavones and total tofu equivalents and when deaths from coronary heart disease (n = 2697) and stroke (n = 1298) were considered separately. When stratified by sex, HRs for cardiovascular disease mortality across quartiles of soy protein were 1.00, 1.00, 1.05, and 1.16 (95% CI: 1.03, 1.31) in men (P-trend = 0.02) and 1.00, 1.01, 0.96, and 0.95 (95% CI: 0.81, 1.10) in women (P-trend = 0.31), although the interaction was not significant (P-interaction = 0.12). In conclusion, soy intake was not significantly associated with risk of cardiovascular disease mortality in the Chinese population. However, a slightly increased risk associated with high soy protein intake in men cannot be excluded and requires further investigation.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24699802      PMCID: PMC4018954          DOI: 10.3945/jn.114.190454

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  40 in total

Review 1.  Isoflavones and cardiovascular disease.

Authors:  Antonio Cano; Miguel Angel García-Pérez; Juan José Tarín
Journal:  Maturitas       Date:  2010-08-21       Impact factor: 4.342

Review 2.  Soy, phytoestrogens and metabolism: A review.

Authors:  Christopher R Cederroth; Serge Nef
Journal:  Mol Cell Endocrinol       Date:  2009-03-09       Impact factor: 4.102

Review 3.  The influence of postharvest processing and storage of foodstuffs on the bioavailability of flavonoids and phenolic acids.

Authors:  Rainer Cermak; Alessandra Durazzo; Giuseppe Maiani; Volker Böhm; Dietmar R Kammerer; Reinhold Carle; Wieslaw Wiczkowski; Mariusz K Piskula; Rudolf Galensa
Journal:  Mol Nutr Food Res       Date:  2009-09       Impact factor: 5.914

Review 4.  Soy constituents: modes of action in low-density lipoprotein management.

Authors:  Jan H van Ee
Journal:  Nutr Rev       Date:  2009-04       Impact factor: 7.110

Review 5.  Phytoestrogenic isoflavonoids in epidemiologic and clinical research.

Authors:  Adrian A Franke; Brunhild M Halm; Kerry Kakazu; Xingnan Li; Laurie J Custer
Journal:  Drug Test Anal       Date:  2009-01       Impact factor: 3.345

6.  Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials.

Authors:  Zhao-Min Liu; Yu-Ming Chen; Suzanne C Ho
Journal:  Am J Clin Nutr       Date:  2011-03-02       Impact factor: 7.045

Review 7.  Antidiabetic effects of fermented soybean products on type 2 diabetes.

Authors:  Dae Young Kwon; James W Daily; Hyun Jin Kim; Sunmin Park
Journal:  Nutr Res       Date:  2010-01       Impact factor: 3.315

Review 8.  The effects of dietary and nutrient interventions on arterial stiffness: a systematic review.

Authors:  Matthew P Pase; Natalie A Grima; Jerome Sarris
Journal:  Am J Clin Nutr       Date:  2010-12-08       Impact factor: 7.045

Review 9.  Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature.

Authors:  Kristen M Beavers; Satya S Jonnalagadda; Mark J Messina
Journal:  Nutr Rev       Date:  2009-04       Impact factor: 7.110

Review 10.  Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis.

Authors:  Jill M Hamilton-Reeves; Gabriela Vazquez; Sue J Duval; William R Phipps; Mindy S Kurzer; Mark J Messina
Journal:  Fertil Steril       Date:  2009-06-12       Impact factor: 7.329

View more
  18 in total

1.  Dairy, soy, and calcium consumption and risk of cognitive impairment: the Singapore Chinese Health Study.

Authors:  Mohammad Talaei; Lei Feng; Jian-Min Yuan; An Pan; Woon-Puay Koh
Journal:  Eur J Nutr       Date:  2019-06-03       Impact factor: 5.614

Review 2.  Role of phytoestrogens in prevention and management of type 2 diabetes.

Authors:  Mohammad Talaei; An Pan
Journal:  World J Diabetes       Date:  2015-03-15

Review 3.  Put "gender glasses" on the effects of phenolic compounds on cardiovascular function and diseases.

Authors:  Ilaria Campesi; Maria Marino; Manuela Cipolletti; Annalisa Romani; Flavia Franconi
Journal:  Eur J Nutr       Date:  2018-04-25       Impact factor: 5.614

4.  Association of soy food with cardiovascular outcomes and all-cause mortality in a Chinese population: a nationwide prospective cohort study.

Authors:  Ting Xue; Junping Wen; Qin Wan; Guijun Qin; Li Yan; Guixia Wang; Yingfen Qin; Zuojie Luo; Xulei Tang; Yanan Huo; Ruying Hu; Zhen Ye; Lixin Shi; Zhengnan Gao; Qing Su; Yiming Mu; Jiajun Zhao; Lulu Chen; Tianshu Zeng; Xuefeng Yu; Qiang Li; Feixia Shen; Li Chen; Yinfei Zhang; Youmin Wang; Huacong Deng; Chao Liu; Shengli Wu; Tao Yang; Mian Li; Yu Xu; Min Xu; Tiange Wang; Zhiyun Zhao; Jieli Lu; Yufang Bi; Weiqing Wang; Gang Chen; Guang Ning
Journal:  Eur J Nutr       Date:  2022-01-10       Impact factor: 5.614

5.  Association of equol producing status with aortic calcification in middle-aged Japanese men: The ERA JUMP study.

Authors:  Xiao Zhang; Akira Fujiyoshi; Vasudha Ahuja; Abhishek Vishnu; Emma Barinas-Mitchell; Aya Kadota; Katsuyuki Miura; Daniel Edmundowicz; Hirotsugu Ueshima; Akira Sekikawa
Journal:  Int J Cardiol       Date:  2022-02-02       Impact factor: 4.164

6.  Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study.

Authors:  Mohammad Talaei; Bee L Lee; Choon N Ong; Rob M van Dam; Jian M Yuan; Woon P Koh; An Pan
Journal:  Br J Nutr       Date:  2016-03-07       Impact factor: 3.718

7.  Consumption of soy products and cardiovascular mortality in people with and without cardiovascular disease: a prospective cohort study of 0.5 million individuals.

Authors:  Xiaowen Wang; Canqing Yu; Jun Lv; Liming Li; Yonghua Hu; Keyang Liu; Kokoro Shirai; Hiroyasu Iso; Jia-Yi Dong
Journal:  Eur J Nutr       Date:  2021-06-02       Impact factor: 5.614

8.  Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in women.

Authors:  Danxia Yu; Xiao-Ou Shu; Honglan Li; Gong Yang; Qiuyin Cai; Yong-Bing Xiang; Bu-Tian Ji; Adrian A Franke; Yu-Tang Gao; Wei Zheng; Xianglan Zhang
Journal:  Am J Clin Nutr       Date:  2015-08-05       Impact factor: 7.045

9.  Diet-Quality Indexes Are Associated with a Lower Risk of Cardiovascular, Respiratory, and All-Cause Mortality among Chinese Adults.

Authors:  Nithya Neelakantan; Woon-Puay Koh; Jian-Min Yuan; Rob M van Dam
Journal:  J Nutr       Date:  2018-08-01       Impact factor: 4.798

10.  Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration.

Authors:  Pao-Hsien Huang; Stephen Chu-Sung Hu; Chiang-Wen Lee; An-Chi Yeh; Chih-Hua Tseng; Feng-Lin Yen
Journal:  Int J Nanomedicine       Date:  2016-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.